您的当前位置:首页 > 行业数据 > 抗IL-1β人源化单克隆抗体注射(613)研究进展
图片属性
图片格式:PNG 图片大小:112KB 图片尺寸:2245*441
同报告图片
 / 4
抗IL-1β人源化单克隆抗体注射(613)研究进展_第1页
5Lul5LiL5piv5qC55o2u5oKo5o+Q5L6b55qE5Zu+54mH55Sf5oiQ55qE5pWw5o2u6KGo5qC877yaCgp8IDIwMjTlubTovr7miJDnmoTph43opoHph4znqIvnopEgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDIwMjXlubTorqHliJLovr7miJDnmoTph43opoHph4znqIvnopEgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18Cnwg5a6M5oiQ5oCl5oCn55eb6aOO5oCn5YWz6IqC54KO6YCC5bqU55eH55qE5Li05bqKSUlJ5pyf5omA5pyJ5Y+X6K+V6ICF5YWl57uE77ybICAgICAgICAgICAgICAgICAgICAgfCDlrozmiJDmgKXmgKfnl5vpo47mgKflhbPoioLngo7pgILlupTnl4fnmoTkuLTluopJSUnmnJ/noJTnqbblubbpgJLkuqROREHnlLPor7fvvJsgICAgICAgICAgICAgICAgICAgICB8Cnwg5a6M5oiQ55eb6aOO5oCn5YWz6IqC54KO6Ze05q2H5pyf6YCC5bqU55eH55qE5Li05bqKSUlJ5pyf5omA5pyJ5Y+X6K+V6ICF5YWl57uE44CCICAgICAgICAgICAgICAgICAgIHwg5a6M5oiQ55eb6aOO5oCn5YWz6IqC54KO6Ze05q2H5pyf6YCC5bqU55eH5Li05bqKSUlJ5pyf56CU56m277yM5bm25ZCv5Yqo5Li05bqKSUlJ5pyf5YWl57uE44CCICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOWFrOWRiu+8jOS4nOaWuei0ouWvjOivgeWIuOeglOeptuaJgA==
抗IL-1β人源化单克隆抗体注射(613)研究进展_第2页
fCDlubTku70gfCDmgqPnl4XkurrmlbDvvIjljYPkurrvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18CnwgMjAyM0UgfCA2MTAwIHwKfCAyMDI0RSB8IDYxMDAgfAp8IDIwMjVFIHwgNjIwMCB8CnwgMjAyNkUgfCA2MzAwIHwKfCAyMDI3RSB8IDY0MDAgfAp8IDIwMjhFIHwgNjUwMCB8CnwgMjAyOUUgfCA2NjAwIHwKfCAyMDMwRSB8IDY3MDAgfAoK6LWE5paZ5p2l5rqQ77ya5rKZ5Yip5paH77yM5Lit5Y2O5Yy75a2m5Lya6aOO5rm/55eF5a2m5YiG5Lya77yM5LiJ55Sf5Zu95YGl5oub6IKh6K+05piO5Lmm77yM5Lic5pa56LSi5a+M6K+B5Yi456CU56m25omA
抗IL-1β人源化单克隆抗体注射(613)研究进展_第3页
抗IL-1β人源化单克隆抗体注射(613)研究进展_第4页
抗IL-1β人源化单克隆抗体注射(613)研究进展_第5页
所属报告: 三生国健-公司深度研究:自免项目顺利推进多个品种开花结果-250620(42页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠